RxDoctor Payments DataLook up a doctor →

Anne Connolly

Neurology with Special Qualifications in Child Neurology · Columbus, OHNPI 1063438380

Payments from drug & device makers

$4,197,391in general payments, 2019–2025

Across 1,130 payments — averaging $3714.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sarepta Therapeutics, Inc.$3.7M
  • Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$311K
  • Novartis$135K
  • Pfizer$29K
  • Hoffmann-la Roche Limited$23K
  • Genentech USA, Inc.$13K
  • plus $12K from 5 others
$7,997in research payments, 2019–2025

Across 3 payments — averaging $2665.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$6K
  • Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$1K
  • Octapharma USA, Inc.$500

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sarepta Therapeutics, Inc.939$3,674,998
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)154$311,117
Novartis7$134,858
Pfizer5$28,872
Hoffmann-la Roche Limited4$23,039
Genentech USA, Inc.11$12,725
Genentech, Inc.1$6,900
PTC Therapeutics, Inc.5$2,574
Mallinckrodt Enterprises LLC1$2,064
Biogen1$199
Catalyst Pharmaceuticals, Inc.2$45

How this compares

$4,197,391 in reported general payments places this provider in the 95th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio →

Other neurology with special qualifications in child neurology in Columbus

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →